US 505(b)(2) Regulatory Pathway and Strategies
US 505(b)(2) Regulatory Pathway and Strategies
US 505(b)(2) Regulatory Pathway and Strategies
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>505</strong>(b)(2) NDAReference Listed Drug (RLD)• A drug product that has been previouslyapproved by the FDA• Listed in the Orange Book• Approval documents contain some of theinformation needed for your <strong>505</strong>(b)(2)7